Literature DB >> 2982657

Inhibitory effect of atrial natriuretic factor on adenylate cyclase activity in adrenal cortical membranes.

M B Anand-Srivastava, J Genest, M Cantin.   

Abstract

The effect of rat synthetic atrial natriuretic factor (ANF) on adenylate cyclase activity was studied in adrenal cortical membranes. Synthetic ANF (Arg 101-Tyr 126) inhibited adenylate cyclase activity in a concentration-dependent manner. The maximum inhibition observed was about 25% with an apparent ki of 5 X 10(-11) to 10(-10) M. Various hormones such as isoproterenol, dopamine, prostaglandin (PGE1) and ACTH-stimulated adenylate cyclase to various degrees and ANF inhibited the stimulatory effect of all these hormones to some degree but never abolished it. In addition, ANF was also able to inhibit the stimulation exerted by forskolin which activates adenylate cyclase by receptor-independent mechanism. This is the first study demonstrating the inhibitory effect of ANF on adrenal cortical adenylate cyclase. From these results it can be suggested that the inhibition of adenylate cyclase may be one of the mechanisms through which ANF exerts the inhibitory effect on steroidogenesis stimulated by various hormones and agents.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982657     DOI: 10.1016/0014-5793(85)80259-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Atrial natriuretic peptide involvement in human platelet aggregability in vitro.

Authors:  R Pella; A von Ruecker; F Bidlingmaier
Journal:  Klin Wochenschr       Date:  1988-01-15

2.  Atrial natriuretic factor receptors in rat kidney, adrenal gland, and brain: autoradiographic localization and fluid balance dependent changes.

Authors:  D R Lynch; K M Braas; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

3.  The presence of atrial-natriuretic-factor receptors of ANF-R2 subtype in rat platelets. Coupling to adenylate cyclase/cyclic AMP signal-transduction system.

Authors:  M B Anand-Srivastava; J Gutkowska; M Cantin
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

4.  Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues.

Authors:  C Bianchi; J Gutkowska; G Thibault; R Garcia; J Genest; M Cantin
Journal:  Histochemistry       Date:  1985

5.  Characterization of ANF-R2 receptor-mediated inhibition of adenylate cyclase.

Authors:  M B Anand-Srivastava
Journal:  Mol Cell Biochem       Date:  1992-07-06       Impact factor: 3.396

6.  Atrial natriuretic factor reduces cyclic adenosine monophosphate content of human fibroblasts by enhancing phosphodiesterase activity.

Authors:  M A Lee; R E West; J Moss
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

7.  Effect of PT-treatment on ANP-mediated inhibition of adenylate cyclase and amylase release in rat parotid gland.

Authors:  H Shimomura; T Nashida; A Imai
Journal:  Mol Cell Biochem       Date:  1994-10-12       Impact factor: 3.396

8.  Atrial natriuretic factor inhibits metoclopramide stimulated aldosterone release in man.

Authors:  C C Lang; A R Rahman; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

9.  Natriuretic peptide receptor-C agonist attenuates the expression of cell cycle proteins and proliferation of vascular smooth muscle cells from spontaneously hypertensive rats: role of Gi proteins and MAPkinase/PI3kinase signaling.

Authors:  Jasmine El Andalousi; Yuan Li; Madhu B Anand-Srivastava
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.